We are not able to provide medical advice or offer cancer specialist referrals
|
Campaign 2019! We achieved our initial $60,000 goal as of 1 October! And we have reached the $10,000 mark towards our goal of $20,000 USD so we can offer a smaller-scale Pilot Award. Pilot awards are often research on innovative ideas carried out as a special project by the lab Help us reach our goal |
We will be offering a $120,000 GCT-specific research operating grant in 2019 in collaboration with the Cancer Research Society. We are now trying to raise an additional $20,000 in order to offer a smaller-scale Pilot Award. Pilot awards can produce data to be used as evidence for larger grants (like an operating grant). Please visit our Donation Page to help us reach our goal, and check out our current research activities |
|
|
|
|
Shop Amazon, Help our Research, No-brainer!
Use our Amazon portal and we receive a commission for our research fund Amazon.com Amazon Canada Amazon UK And make this portal your Amazon Bookmark! |
GCTRF has enrolled as an Keep up to date with the latest information on research and advocacy for the wider ovarian cancer community |
|
|
|
Inhibin testing
We realise that there is inconsistent offering of Inhibin and AMH testing in Canada, and possibly elsewhere. ARUP Labs in Salt Lake City, Utah, is one lab that can test for both markers and will accept samples from patients. These links provide instructions for international sample submission, a sample order form (cost is $98 USD but may vary), and instructions specific to Canadian submissions. Be sure to contact ARUP directly before arranging collection of your sample to ensure you have the latest information. |
|
|
|
Where in the world are we!
Three of our sisters, Terri, Dianne, and Sue, have put together this poster showing the world-wide distribution of our GCT 'family'. Have a look! |
|
|
|
Presentations from GCT Sisters Weekend 2016
We collected presentations from speakers who participated in our 2016 GCT Sisters Weekend. Presentations Kunle Odunsi - Roswell Park Cancer Institute, USA Granulosa cell tumors and Immunotherapy for ovarian cancer Aniina Farkkila - University of Helsinki, Finland Optimizing follow-up after adult granulosa cell tumor Ulla-Maija Haltia - University of Helsinki, Finland Current treatment of AGCT and future perspectives Powel Crosley - University of Alberta, Canada Combining apoptosis-inducing agents in treatment of granulosa cell tumour Alan Klitzke - Roswell Park Cancer Institute, USA Imaging modalities for granulosa cell tumour Photos from GCTSW 2016 |
|
|
|
GCTRF is a registered, 100% volunteer foundation
The foundation is registered with the US Internal Revenue Service as a 501(c)(3) charity. When you donate to GCTRF 100% of that donation goes to researchers due to the fact that we are a totally volunteer organisation and utilise a private grant to cover operating expenses. We pay no salaries and no director's fees. When you donate your hard-earned money you deserve to know that it is going to the purposes for which you donated! |